Immunogen sequence: LLESFCIPGL WNEADMEVIV GDFGIVVVPR DAADTDRIMN HSSILRKYKN NIMVVKDDIN HPMSVVSSTK SRLALQHGDG HVVD
Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form; nicotinic acid mononucleotide (NaMN) as substrate but with a lower efficiency. Cannot use triazofurin monophosphate (TrMP) as substrate. Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+). For the pyrophosphorolytic activity prefers NAD(+), NADH and NAAD as substrates and degrades nicotinic acid adenine dinucleotide phosphate (NHD) less effectively. Fails to cleave phosphorylated dinucleotides NADP(+), NADPH and NAADP(+).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: C1orf15; KIAA0479; NaMN adenylyltransferase 2; Nicotinamide mononucleotide adenylyltransferase 2; Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2; Nicotinate-nucleotide adenylyltransferase 2; NMN adenylyltransferase 2; NMN/NaMN adenylyltransferase 2; PNAT2; pyridine nucleotide adenylyltransferase 2
Gene Aliases: C1orf15; KIAA0479; NMNAT2; PNAT2
UniProt ID: (Human) Q9BZQ4
Entrez Gene ID: (Human) 23057